Insider · CIK 0001745955
Kathryn E Wengel
Files at JNJ (JOHNSON & JOHNSON), LH (LABORATORY CORP OF AMERICA HOLDINGS). First filing Jun 12, 2026, latest Jun 12, 2026.
In brief
Kathryn E Wengel files SEC Form 4 as officer and director at JNJ (JOHNSON & JOHNSON), and also at LH (LABORATORY CORP OF AMERICA HOLDINGS). Since Jun 12, 2026, Kathryn E Wengel has reported 0 open-market buys worth $0 and 1 open-market sell worth $2.4M, the latest filed on Jun 12, 2026.
A track record needs three past buys with six months of prices behind them; Kathryn E Wengel has 0, so none is measured yet.
The newest scored trade: sold $2.4M of JNJ on Jun 11, 2026, filed Jun 12, 2026, scored 25 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $2.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JNJ: JOHNSON & JOHNSON
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | JNJsell JOHNSON & JOHNSON | $2.4M 10,000 shares | -8% | +63% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 11, 2026 | JNJ JOHNSON & JOHNSON | 10,000 0.00% of outstanding | $2.4M | Jun 11, 2026 | none |
Transactions
Every row this insider has filed, 45 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +10,000 | $115.67 | $1.2M | 124,288 | Jun 12, 2026 |
| Jun 11, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -10,000 | $241.15 | $2.4M | 114,288 | Jun 12, 2026 |
| Jun 11, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -10,000 | $0.00 | $0 | 32,965 | Jun 12, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +651 | $0.00 | $0 | 106,607 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -217 | $244.55 | $53k | 106,390 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +13,706 | $0.00 | $0 | 120,096 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -6,414 | $244.55 | $1.6M | 113,682 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +606 | $0.00 | $0 | 114,288 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -310 | $243.45 | $75k | 113,978 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +635 | $0.00 | $0 | 114,613 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -325 | $243.45 | $79k | 114,288 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -651 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -13,706 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -606 | $0.00 | $0 | 606 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -635 | $0.00 | $0 | 1,268 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +16,945 | $0.00 | $0 | 16,945 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +1,217 | $0.00 | $0 | 1,217 | Feb 18, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +897 | - | - | 4,133 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -897 | $0.00 | $0 | 773 | Feb 13, 2026 |
| Feb 10, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Restricted Stock Unitderivative | +773 | $0.00 | $0 | 1,670 | Feb 12, 2026 |
| Feb 9, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +13,706 | $0.00 | $0 | 13,706 | Feb 11, 2026 |
| Feb 6, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +38,945 | $101.87 | $4.0M | 133,226 | Feb 9, 2026 |
| Feb 6, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -27,270 | $239.99 | $6.5M | 105,956 | Feb 9, 2026 |
| Feb 6, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -38,945 | $101.87 | $4.0M | 0 | Feb 9, 2026 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +30,841 | $0.00 | $0 | 30,841 | Feb 19, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +1,903 | $0.00 | $0 | 1,903 | Feb 19, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +651 | $0.00 | $0 | 89,603 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -223 | $155.26 | $35k | 89,380 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,530 | $0.00 | $0 | 90,910 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -480 | $156.71 | $75k | 90,430 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +607 | $0.00 | $0 | 91,037 | Feb 18, 2025 |
| Feb 18, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -200 | $156.15 | $31k | 90,837 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +5,837 | $0.00 | $0 | 96,674 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -2,393 | $156.71 | $375k | 94,281 | Feb 18, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -651 | $0.00 | $0 | 651 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,530 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -607 | $0.00 | $0 | 1,212 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -5,837 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 11, 2025 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Restricted Stock Unitderivative | +897 | $0.00 | $0 | 897 | Feb 13, 2025 |
| Feb 10, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +5,837 | $0.00 | $0 | 5,837 | Feb 12, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +32,762 | $100.06 | $3.3M | 115,028 | Feb 11, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -26,076 | $153.12 | $4.0M | 88,952 | Feb 11, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -32,762 | $100.06 | $3.3M | 0 | Feb 11, 2025 |
| Feb 6, 2025 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +944 | - | - | 3,236 | Feb 10, 2025 |
| Feb 6, 2025 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -944 | $0.00 | $0 | 0 | Feb 10, 2025 |
Questions about Kathryn E Wengel
Answered from the filings on this page, as of the latest one.
Is Kathryn E Wengel buying or selling?
In the last 12 months Kathryn E Wengel reported 0 open-market buys worth $0 and 1 open-market sell worth $2.4M on SEC Form 4; the latest was sold $2.4M of JNJ on Jun 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Kathryn E Wengel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathryn E Wengel has 0.
Where does Kathryn E Wengel file Form 4?
Kathryn E Wengel has filed Form 4 at JNJ (JOHNSON & JOHNSON) as EVP, Chief TO and Risk Officer; LH (LABORATORY CORP OF AMERICA HOLDINGS). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.